Hydrochloric Acid → (2R)-4-(4-cyano-1H-pyrazol-1-yl)-N-hydroxy-2-methyl-2-(methylsulfonyl)butanamide
Reaction equation
[C:1]([C:3]1[CH:4]=[N:5][N:6]([CH2:8][CH2:9][C@@:10]([CH3:25])([S:21]([CH3:24])(=[O:23])=[O:22])[C:11]([NH:13][O:14]C2CCCCO2)=[O:12])[CH:7]=1)#[N:2].Cl>CCO>[C:1]([C:3]1[CH:4]=[N:5][N:6]([CH2:8][CH2:9][C@@:10]([CH3:25])([S:21]([CH3:24])(=[O:22])=[O:23])[C:11]([NH:13][OH:14])=[O:12])[CH:7]=1)#[N:2]Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of (2R)-4-(4-cyano-1H-pyrazol-1-yl)-2-methyl-2-(methylsulfonyl)-N-(tetrahydro-2H-pyran-2-yloxy)butanamide (0.165 g, 0.445 mmol) in EtOH (20 mL) was added HCl (1 M solution, 5 mL). The reaction mixture was allowed to stir at room temperature overnight. The reaction mixture was concentrated and was purified via reverse-phase chromatography system, using 5%-95% acetonitrile/water with 0.1% formic acid modifier as the gradient elution solvent. Target fractions were combined and evaporated to yield (2R)-4-(4-cyano-1H-pyrazol-1-yl)-N-hydroxy-2-methyl-2-(methylsulfonyl)butanamide (21 mg, 16% yield) as a white solid. 1H NMR (400 MHz, DMSO-d6) δ 1.47 (s, 3H), 2.16-2.33 (m, 1H), 2.59-2.80 (m, 1H), 3.04 (s, 3H), 3.96-4.17 (m, 1H), 4.18-4.39 (m, 1H), 8.05 (s, 1H) 8.57 (s, 1H), 9.24 (br. s., 1H) 10.97 (br. s., 1H). LC-MS M−H 285.3.
Workup
- concentrationThe reaction mixture was concentrated
- customwas purified via reverse-phase chromatography system
- washas the gradient elution solvent
- customevaporated
Sources & evidence
- ORD record
- ord-6aed19d6d6f5411f96ad82d3efcbda89
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08809333B2
Reaction notes
Loading…